Finance

Lists
QTTB:NASDAQ
Q32 Bio Inc
US$15,15
-1,50%
(-0,23) 1D
24 ກ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QTTB...
Open
US$15,26
High
US$15,59
Low
US$14,97
Mkt. cap
໓໑໒,໙໕ ລ້ານ
Avg. vol.
໑,໘໘ ລ້ານ
Volume
໑໗໘,໘໔ ພັນ
P/E ratio
໕,໗໑
52-wk high
US$23,57
52-wk low
US$1,57
EPS
US$2,65
Beta
໐,໒໔
Shares outstanding
໒໙,໗໖ ລ້ານ
No. of employees
໒໒
Open
US$15,26
High
US$15,59
Low
US$14,97
Mkt. cap
໓໑໒,໙໕ ລ້ານ
Avg. vol.
໑,໘໘ ລ້ານ
Volume
໑໗໘,໘໔ ພັນ
P/E ratio
໕,໗໑
52-wk high
US$23,57
52-wk low
US$1,57
EPS
US$2,65
Beta
໐,໒໔
Shares outstanding
໒໙,໗໖ ລ້ານ
No. of employees
໒໒
News stories
From sources across the web
About Q32 Bio Inc
CEO-
Employees22
Founded2017
HeadquartersWaltham, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websiteq32bio.com
Analyst ratings
Based on 5 analysts giving stock ratings to QTTB in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for QTTB in the last 3 months.
Highest
Current US$15,15
US$66,00 (+335,64%)
Average
US$38,75 (+155,78%)
Lowest
US$13,00 (-14,19%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Catanzaro
Mizuho Securities
Buy
Reiterated
US$36,00
+137,6%
07/13/2026
Jay Olson
Oppenheimer
Buy
Maintained
US$40,00
+164%
07/13/2026
Derek Archila
Wells Fargo
Buy
Upgraded
US$66,00
+335,6%
07/14/2026
Richard Poland
Wells Fargo
Hold
Maintained
US$10,00
-34%
05/28/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
US$10,00
-34%
05/28/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Initiated
-
-
05/18/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
05/18/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
05/18/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
US$13,00
-14,2%
05/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
-
-
53,74 ລ້ານ
-
Cost of goods sold
280,00 ພັນ
3,56 ລ້ານ
3,32 ລ້ານ
3,22 ລ້ານ
Cost of revenue
280,00 ພັນ
3,56 ລ້ານ
3,32 ລ້ານ
3,22 ລ້ານ
Research and development expenses
4,88 ລ້ານ
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,01 ລ້ານ
4,02 ລ້ານ
4,54 ລ້ານ
4,50 ລ້ານ
Operating expense
8,89 ລ້ານ
4,02 ລ້ານ
4,54 ລ້ານ
4,50 ລ້ານ
Total operating expenses
9,17 ລ້ານ
7,58 ລ້ານ
7,86 ລ້ານ
7,72 ລ້ານ
Operating income
-9,17 ລ້ານ
-7,58 ລ້ານ
45,88 ລ້ານ
-7,72 ລ້ານ
Other non operating income
-618,00 ພັນ
-12,00 ພັນ
-12,00 ພັນ
-79,00 ພັນ
EBT including unusual items
-9,49 ລ້ານ
-7,39 ລ້ານ
57,73 ລ້ານ
-7,61 ລ້ານ
EBT excluding unusual items
-9,49 ລ້ານ
-7,39 ລ້ານ
46,07 ລ້ານ
-7,61 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,49 ລ້ານ
-7,39 ລ້ານ
57,73 ລ້ານ
-7,61 ລ້ານ
Net profit margin
-
-
107,43%
-
Earnings per share
-
-
-
-
Interest and investment income
600,00 ພັນ
500,00 ພັນ
400,00 ພັນ
392,00 ພັນ
Interest expense
-300,00 ພັນ
-300,00 ພັນ
-200,00 ພັນ
-200,00 ພັນ
Net interest expenses
300,00 ພັນ
200,00 ພັນ
200,00 ພັນ
192,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,08 ລ້ານ
-7,49 ລ້ານ
45,97 ລ້ານ
-7,63 ລ້ານ
Gain or loss from assets sale
-
-
-11,74 ລ້ານ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer